Novanta - Common Shares (NOVT) closed at $139.94 on October 21, 2026, up 3.2% from the previous close, on volume of 371,786 shares (30-day average 404,738).
Data as of October 21, 2026.
21-Oct-2026
Market Chameleon (Wed, 21-Oct 7:56 AM ET)
Novanta to Present at the Baird 2026 Global Industrial Conference on Wednesday, November 11, 2026
Business Wire (Tue, 20-Oct 3:02 PM ET)
Novanta Inc. Announces Schedule of Third Quarter 2026 Earnings Release and Conference Call
Business Wire (Tue, 13-Oct 5:00 PM ET)
Novanta to Present at Baird Global Healthcare Conference on Tuesday, September 15, 2026
Business Wire (Fri, 28-Aug 5:00 PM ET)
Novanta Announces Financial Results for the Second Quarter 2026
Business Wire (Wed, 5-Aug 4:45 PM ET)
Novanta Completes Acquisition of Riverpoint Medical
Business Wire (Mon, 27-Jul 8:00 AM ET)
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.
Novanta - Common Shares trades on the NASDAQ stock market under the symbol NOVT.
As of October 21, 2026, NOVT stock price climbed to $139.94 with 371,786 million shares trading.
NOVT has a beta of 2.27, meaning it tends to be more sensitive to market movements. NOVT has a correlation of 0.29 to the broad based SPY ETF.
NOVT has a market cap of $4.98 billion. This is considered a Mid Cap stock.
Last quarter Novanta - Common Shares reported $266 million in Revenue and $.89 earnings per share. This beat revenue expectation by $4 million and exceeded earnings estimates by $.06.
In the last 3 years, NOVT traded as high as $187.12 and as low as $98.27.
The top ETF exchange traded funds that NOVT belongs to (by Net Assets): IJH, VTI, IWM, VB, VGT.
NOVT has outperformed the market in the last year with a return of +23.8%, while the SPY ETF gained +16.3%. However, in the most recent history, NOVT shares have underperformed the stock market with its stock returning -4.1% in the last 3 month period and -2.6% for the last 2 week period, while SPY has returned +3.6% and -0.5%, respectively.
NOVT support price is $131.74 and resistance is $139.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NOVT shares will trade within this expected range on the day.
